KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other Non-Current Assets: 2015-2024

Historic Other Non-Current Assets for BeOne Medicines (ONC) over the last 8 years, with Dec 2024 value amounting to $160.5 million.

  • BeOne Medicines' Other Non-Current Assets fell 32.30% to $136.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.2 million, marking a year-over-year decrease of 32.30%. This contributed to the annual value of $160.5 million for FY2024, which is 28.02% up from last year.
  • As of FY2024, BeOne Medicines' Other Non-Current Assets stood at $160.5 million, which was up 28.02% from $125.4 million recorded in FY2023.
  • Over the past 5 years, BeOne Medicines' Other Non-Current Assets peaked at $163.0 million during FY2021, and registered a low of $7.7 million during FY2020.
  • For the 3-year period, BeOne Medicines' Other Non-Current Assets averaged around $120.3 million, with its median value being $125.4 million (2023).
  • Per our database at Business Quant, BeOne Medicines' Other Non-Current Assets soared by 2,004.40% in 2021 and then slumped by 53.93% in 2022.
  • BeOne Medicines' Other Non-Current Assets (Yearly) stood at $7.7 million in 2020, then surged by 2,004.40% to $163.0 million in 2021, then tumbled by 53.93% to $75.1 million in 2022, then spiked by 66.89% to $125.4 million in 2023, then grew by 28.02% to $160.5 million in 2024.